Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07415187 · ClinicalTrials.gov registry record

The Impact of Skin Tone on Pulse Oximeter Accuracy

A clinical trial of Accuracy of Pulse Oximetry Across Skin Pigmentation Levels, sponsored by Rush University Medical Center.

Recruiting
Registry status
194
Enrollment target
1
Study location

NCT07415187: Recruiting study of Accuracy of Pulse Oximetry Across Skin Pigmentation Levels, sponsored by Rush University Medical Center.

NCT07415187 is a study of Accuracy of Pulse Oximetry Across Skin Pigmentation Levels that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 194 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07415187, a study of Accuracy of Pulse Oximetry Across Skin Pigmentation Levels, is actively recruiting participants, sponsored by Rush University Medical Center.

RECRUITING
Registry status
194 participants
Enrollment target
1
Study location

Study Summary

Pulse oximeters are widely used in hospitals to estimate blood oxygen levels using a sensor placed on the skin. Recent studies suggest that pulse oximeter readings may be less accurate in individuals with darker skin tones, which could delay recognition of low oxygen levels. The purpose of this study is to evaluate the accuracy of pulse oximeters across a range of skin tones and to identify factors associated with differences between pulse oximeter readings and oxygen levels measured directly from blood. This is an observational cohort study involving adult patients who are already undergoing an arterial blood gas (ABG) test as part of routine clinical care. The ABG test is not performed for research purposes and is not altered by participation in the study. At the time the ABG sample is obtained, two commercially available pulse oximeters will be temporarily placed on the participant's finger to record oxygen saturation values. These readings will be compared with the oxygen saturation measured from the arterial blood sample. Pulse oximeter measurements collected for the study will not be used for clinical decision-making. Skin tone will be assessed using both self-reported race/ethnicity and an objective, noninvasive skin pigmentation measurement device. This approach allows evaluation of the relationship between skin pigmentation and pulse oximeter accuracy. Participation in the study involves minimal risk. No additional blood samples, medications, or treatments are required. The study does not alter standard medical care. The findings from this study may improve understanding of pulse oximeter performance and help inform future efforts to reduce measurement bias and improve patient safety.

Interventions

  • OTHER There is no intervention

Study Locations (1)

Illinois

  • Rush University Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 194 participants
Start Date 2023-04-01
Est. Completion 2027-12
Rush University Medical Center

320 total trials

What NCT07415187 shows while recruiting

NCT07415187 is an observational study that tracks outcomes without assigning an intervention. The registered 194 participants enrollment target is mid-sized for trials with a published cap.

The record links to 1 condition, with Accuracy of Pulse Oximetry Across Skin Pigmentation Levels appearing as the primary indexed condition, and to 1 intervention - of which There is no intervention is the first listed.

NCT07415187 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT07415187 about?

NCT07415187 is a clinical study titled "The Impact of Skin Tone on Pulse Oximeter Accuracy". Pulse oximeters are widely used in hospitals to estimate blood oxygen levels using a sensor placed on the skin. Recent studies suggest that pulse oximeter readings may be less accurate in individuals with darker skin tones, which could delay recognition of low oxygen levels. The purpose of this stu...

What is the current status of trial NCT07415187?

This trial is currently recruiting. The enrollment target is 194 participants. The study started on 2023-04-01. Estimated completion is 2027-12.

What conditions does trial NCT07415187 study?

This clinical trial studies the following conditions: Accuracy of Pulse Oximetry Across Skin Pigmentation Levels.

What interventions are being tested in trial NCT07415187?

The interventions under investigation include: There is no intervention (OTHER).

Who is sponsoring clinical trial NCT07415187?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07415187 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03593759 · 194 participants · Phase 3

    Cardiac Sarcoidosis Randomized Trial

  • NCT05053152 · 194 participants · Phase 2

    Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

  • NCT05156112 · 194 participants · NA

    OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit

  • NCT05351424 · 194 participants · NA

    AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07415187, the US trial registry maintained by the National Library of Medicine. NCT07415187 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.